Sapience Therapeutics, Inc. logo

Sapience Therapeutics, Inc.

Sapience Therapeutics is focused on discovering and developing peptide-based therapeutics to previously ‘undruggable’ targets for major unmet medical needs, particularly high mortality cancers. Sapience identifies promising targets through a deep understanding of the transcriptional regulation of oncogenic or immune-modulatory proteins. Our targets are non-traditional in drug discovery as they do not demonstrate enzymatic activities or act as ligand-binding receptors. Sapience has multiple approaches to generate initial hits, which are then optimized based on decades of experience working with peptide and protein therapeutics. ST101 went from concept to clinical candidate in less than 9 months.

0
Management
0
Technology
0
Deals/Partnering
0
Research Pipeline
0
Funding
BioStartup's Score 0 / 50

KEY DETAILS

Websitehttps://www.sapiencetherapeutics.com
Founded2015
Disease Focus
Development Stage
STOCK CODENon Listed
Address
500 Mamaroneck Ave Suite 320, NY, 10528
Harrison
United States
Email
Contact Number

[atom_linkedin linkedin_option=”CompanyInsider” linkedin_id=”https://www.linkedin.com/company/sapience-therapeutics-inc-” connections=”true” suffix=””]